Across TCGA pan-cancer cohorts, RN7SL333P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RN7SL333P data layer.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL333P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL333P expression acts as an unfavorable survival marker, although some lineages such as HNSC and BRCA show a favorable association.
HNSC, LGG, and KICH are the cancer types where RN7SL333P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.